236 related articles for article (PubMed ID: 15929988)
1. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts.
Ljusberg J; Wang Y; Lång P; Norgård M; Dodds R; Hultenby K; Ek-Rylander B; Andersson G
J Biol Chem; 2005 Aug; 280(31):28370-81. PubMed ID: 15929988
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
[TBL] [Abstract][Full Text] [Related]
3. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity.
Perez-Amodio S; Jansen DC; Schoenmaker T; Vogels IM; Reinheckel T; Hayman AR; Cox TM; Saftig P; Beertsen W; Everts V
Calcif Tissue Int; 2006 Oct; 79(4):245-54. PubMed ID: 17033726
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of monomeric and proteolytically processed forms of tartrate-resistant acid phosphatase in rat tissues.
Lång P; Andersson G
Cell Mol Life Sci; 2005 Apr; 62(7-8):905-18. PubMed ID: 15761664
[TBL] [Abstract][Full Text] [Related]
5. Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR.
Ishibashi O; Inui T; Mori Y; Kurokawa T; Kokubo T; Kumegawa M
Calcif Tissue Int; 2001 Feb; 68(2):109-16. PubMed ID: 11310346
[TBL] [Abstract][Full Text] [Related]
6. Proteinase expression during differentiation of human osteoclasts in vitro.
Blair HC; Sidonio RF; Friedberg RC; Khan NN; Dong SS
J Cell Biochem; 2000 Jun; 78(4):627-37. PubMed ID: 10861860
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits.
Aibe K; Yazawa H; Abe K; Teramura K; Kumegawa M; Kawashima H; Honda K
Biol Pharm Bull; 1996 Aug; 19(8):1026-31. PubMed ID: 8874809
[TBL] [Abstract][Full Text] [Related]
8. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats.
Hie M; Shimono M; Fujii K; Tsukamoto I
Bone; 2007 Dec; 41(6):1045-50. PubMed ID: 17916452
[TBL] [Abstract][Full Text] [Related]
9. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport.
Hollberg K; Hultenby K; Hayman A; Cox T; Andersson G
Exp Cell Res; 2002 Oct; 279(2):227-38. PubMed ID: 12243748
[TBL] [Abstract][Full Text] [Related]
10. Estrogen modulation of osteoclast lysosomal enzyme secretion.
Kremer M; Judd J; Rifkin B; Auszmann J; Oursler MJ
J Cell Biochem; 1995 Feb; 57(2):271-9. PubMed ID: 7759564
[TBL] [Abstract][Full Text] [Related]
11. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.
Vääräniemi J; Halleen JM; Kaarlonen K; Ylipahkala H; Alatalo SL; Andersson G; Kaija H; Vihko P; Väänänen HK
J Bone Miner Res; 2004 Sep; 19(9):1432-40. PubMed ID: 15312243
[TBL] [Abstract][Full Text] [Related]
12. Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis.
Park JK; Rosen A; Saffitz JE; Asimaki A; Litovsky SH; Mackey-Bojack SM; Halushka MK
Rheumatology (Oxford); 2013 Aug; 52(8):1529-33. PubMed ID: 23674817
[TBL] [Abstract][Full Text] [Related]
13. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
14. Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts.
Nakayama T; Mizoguchi T; Uehara S; Yamashita T; Kawahara I; Kobayashi Y; Moriyama Y; Kurihara S; Sahara N; Ozawa H; Udagawa N; Takahashi N
Bone; 2011 Dec; 49(6):1331-9. PubMed ID: 21983021
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts.
Fuller K; Lawrence KM; Ross JL; Grabowska UB; Shiroo M; Samuelsson B; Chambers TJ
Bone; 2008 Jan; 42(1):200-11. PubMed ID: 17962093
[TBL] [Abstract][Full Text] [Related]
16. The effects of colony-stimulating factor-1 (CSF-1) on the development of osteoclasts and their expression of tartrate-resistant acid phosphatase (TRAP) in toothless (tl-osteopetrotic) rats.
Norgård M; Marks SC; Reinholt FP; Andersson G
Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):117-32. PubMed ID: 14696961
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification.
Bossard MJ; Tomaszek TA; Thompson SK; Amegadzie BY; Hanning CR; Jones C; Kurdyla JT; McNulty DE; Drake FH; Gowen M; Levy MA
J Biol Chem; 1996 May; 271(21):12517-24. PubMed ID: 8647860
[TBL] [Abstract][Full Text] [Related]
18. Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts.
Hollberg K; Nordahl J; Hultenby K; Mengarelli-Widholm S; Andersson G; Reinholt FP
J Bone Miner Metab; 2005; 23(6):441-9. PubMed ID: 16261450
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development.
Dodds RA; Connor JR; Drake F; Feild J; Gowen M
J Bone Miner Res; 1998 Apr; 13(4):673-82. PubMed ID: 9556067
[TBL] [Abstract][Full Text] [Related]
20. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.
Xia L; Kilb J; Wex H; Li Z; Lipyansky A; Breuil V; Stein L; Palmer JT; Dempster DW; Brömme D
Biol Chem; 1999 Jun; 380(6):679-87. PubMed ID: 10430032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
